Summary Stage 2018: Skin Eyelid

Summary Stage 2018

Notes

**Skin Eyelid** 8000-8040, 8042-8180, 8191-8246, 8248-8700, 8940-8941, 8980 C441 C441 Eyelid **Note 1:** The following sources were used in the development of this chapter * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 64 *Eyelid Carcinoma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** See the following chapters for the listed histologies * 8041, 8190, 8247: *Merkel Cell Skin* * 8710-8714, 8800-8934, 8950-8975, 8981-9138, 9141-9514, 9520-9582: *Soft Tissue* * 8720-8790: *Melanoma Skin* * 8935-8936: *GIST* * 9140: *Kaposi Sarcoma* * 9700-9701: *Mycosis Fungoides* **Note 3:** Code the tumor with the greatest extension when there are multiple simultaneous tumors. **Note 4:** Full eyelid thickness (code 1) is defined as including skin, orbicularis muscle, tarsus and conjunctiva (palpebral).

NAACCR Item

NAACCR #764
SS2018 Description
0 In situ, intraepithelial, noninvasive - Bowen disease
1 Localized only (localized, NOS) - Eyelid margin - Full thickness of eyelid - Lesion(s) confined to dermis - Minimal infiltration of dermis - Subcutaneous tissue (through entire dermis) - Underlying orbicularis muscle - Tarsal plate - Tarsus
2 Regional by direct extension only - Adjacent structures, NOS - Bone/periosteum of orbit - Bony walls of orbit (invades or evades through) - Bulbar conjunctiva - Intraorbital structures, NOS - Lacrimal sac - Ocular structures - Sclera - Skeletal muscles (except orbicularis muscle of eyelid) - Soft tissues of orbit - Underlying cartilage
3 Regional lymph node(s) involved only - Buccinator (buccal) - Cervical, NOS - Facial, NOS - Intraparotid - Nasolabial - Parotid + Infra-auricular + Preauricular - Submandibular [submaxillary] - Submental - Supraclavicular, NOS - Regional lymph node(s), NOS + Lymph node(s), NOS
4 Regional by BOTH direct extension AND regional lymph node(s) involved - Codes (2) + (3)
7 Distant site(s)/lymph node(s) involved - Distant site(s) (including further contiguous extension) + Brain + Central nervous system (CNS) + Nasal cavity + Nasolacrimal duct + Other craniofacial structures + Paranasal sinus - Distant lymph node(s), NOS - Distant metastasis, NOS + Carcinomatosis + Distant metastasis WITH or WITHOUT distant lymph node(s), NOS + Metastatic skin lesions with or without distant lymph node(s)
9 Unknown if extension or metastasis
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017 (5) Esmaeli, B., Finger, P.T., et al. **Eyelid Carcinoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017